Arachidonate metabolites change furosemide-induced cochlear potentials

Area of Science:

• Oto-pharmacology
• Neuroscience
• Auditory physiology

Background:

• Arachidonic acid metabolites play a role in cochlear function.
• Furosemide, a loop diuretic, alters cochlear potentials, serving as a model for studying these metabolites.

Purpose of the Study:

• To investigate the influence of arachidonic acid metabolites on ion movements in the cochlea.
• To determine the role of thromboxane (TX) and platelet-activating factor (PAF) receptors in furosemide-induced cochlear potential changes.

Main Methods:

• Utilized furosemide-induced changes in cochlear potentials as an experimental model.
• Administered drugs blocking lipoxygenase (Esculetin), thromboxane A2 synthesis (Dazoxiben), TX receptors (BM 13,505, BM 13,177), and PAF receptors (BN 52,021).
• Measured effects on endocochlear potential, summating potential, and cochlear microphonics.

Main Results:

• Esculetin and Dazoxiben showed no significant influence on furosemide-induced changes.
• Infusion of TX receptor antagonists (BM 13,505, BM 13,177) weakened furosemide effects.
• Pre-treatment with a PAF receptor antagonist (BN 52,021) also attenuated furosemide-induced changes.
• Summating potential and cochlear microphonics were not significantly altered.

Conclusions:

• Results suggest that thromboxane receptors are involved in controlling ion movements within the cochlea.
• Platelet-activating factor receptor antagonism also impacts furosemide-induced effects.
• The study discusses a potential role for loop diuretic receptors in cochlear ion transport.